SLEEP AIDS IN THE NETHERLANDS

Euromonitor International

February 2019

LIST OF CONTENTS AND TABLES

Headlines

Prospects

Healthy Growth Is Supported by Sound Fundamentals

OTC Sales Boosted by Lifestyle Changes and Suppression of Prescription Varieties

Regulatory Uncertainty About Melatonin Could Affect Future Growth

Competitive Landscape

Vemedia Continues To Lead Sleep Aids

Product Innovation Is Mostly in Melatonin-based Sleep Aids

Smaller Dutch and Other European Players Continue To Dominate

Category Data

Table 1 Sales of Sleep Aids: Value 2013-2018

Table 2 Sales of Sleep Aids: % Value Growth 2013-2018

Table 3 NBO Company Shares of Sleep Aids: % Value 2014-2018

Table 4 LBN Brand Shares of Sleep Aids: % Value 2015-2018

Table 5 Forecast Sales of Sleep Aids: Value 2018-2023

Table 6 Forecast Sales of Sleep Aids: % Value Growth 2018-2023

Executive Summary

Moderate Value Growth, Largely Driven by Non-otc Categories

OTC Sales Are Not (yet) Lifted by the Brighter Macroeconomy

Pharmaceutical Multinationals Dominate, With Private Label the Main Rival

Supermarkets Gains Ground, To the Detriment of Chemists/pharmacies

Modest Value Growth Over the Forecast Period

Appendix

OTC Registration and Classification

Vitamins and Dietary Supplements Registration and Classification

Self-medication/self-care and Preventive Medicine

Switches

Summary 1 OTC: Switches

Market Indicators

Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018

Table 8 Life Expectancy at Birth 2013-2018

Market Data

Table 9 Sales of Consumer Health by Category: Value 2013-2018

Table 10 Sales of Consumer Health by Category: % Value Growth 2013-2018

Table 11 NBO Company Shares of Consumer Health: % Value 2014-2018

Table 12 LBN Brand Shares of Consumer Health: % Value 2015-2018

Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2013-2018

Table 14 Distribution of Consumer Health by Format: % Value 2013-2018

Table 15 Distribution of Consumer Health by Format and Category: % Value 2018

Table 16 Forecast Sales of Consumer Health by Category: Value 2018-2023

Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023

Sources

Summary 2 Research Sources

Sleep aids registered another year of healthy current value growth in 2018, as the fundamentals for demand remained sound. Modern lifestyles resulted in more of the Dutch population experiencing insomnia, whilst demographic changes swelled the share of the elderly, which constitute a core consumer group. In addition, increasing efforts by health insurers and professionals to curb the use of stronger prescription sleep aids benefited sales of non-prescription products.

Euromonitor International's Sleep Aids in Netherlands report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Sleep Aids market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.